The BCW Index closed up .37 percent for the five-day trading period ended Tuesday. Leading gainers for the week were Qiagen, PerkinElmer, and Molecular Devices, which all rose more than 5 percent for the week. Invitrogen led decliners with a 5.4 percent drop.

In comparison, the Dow Jones Industrial Average fell .1 percent, the Nasdaq climbed 1.1 percent, and the Nasdaq Biotech Index closed up 2.2 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.